CD4 and neoplasm: We assessed the expression of TIGIT in TILs using the MC38 tumor model, and the expression of TIGIT was significantly higher in TILs, including CD4+ TILs, CD8+ TILs, and NK cells, compared with the spleen (Figures 1A, B).